The number of Australian homes bought by foreigners fell last year, as high stamp duty costs deter potential buyers. The downturn reflects the government’s efforts to reduce foreign investment and cut migration, experts say. The number of foreigners purchasing property in Australia dropped last financial year. Credit: Dion Georgopoulos The number of approved residential real estate investments by overseas buyers fell to 5581 in financial year 2024, down from 6576 in 2023 (15 per cent), figures from the Foreign Investment Review Board (FIRB) show. The combined value of approved residential real estate proposals from Chinese and Hong Kong buyers (with China the largest foreign-buyer pool in Australia), dropped last financial year from $4 billion to $3 billion. Property portal Juwai IQI co-founder and group managing director Daniel Ho said affordability has unexpectedly become an issue for foreign buyers here. “Foreign buyers pay much more to purchase and to hold property in Australia than local residents and citizens,” Ho said. “They have extra taxes, fees, and duties that local buyers don’t have to worry about.” In Sydney, foreign buyers pay a one-off application fee, a stamp duty surcharge of 8 per cent and an annual land tax surcharge of 4 per cent. Both components will increase to 9 per cent and 5 per cent, respectively, from next year. Buyers who are not Australian citizens or permanent residents are restricted in the types of dwelling they can purchase. Foreign investors are limited to new dwellings or off-the-plan sales, to help boost Australia’s housing stock. The combined value of approved residential real estate proposals from Chinese and Hong Kong buyers dropped from $4 billion to $3 billion last financial year. Credit: Steven Siewert Temporary residents can apply for approval to buy an established home to live in for the duration of their stay, or can also buy an established home for redevelopment if it increases the housing stock. Plus Agency managing director Peter Li said the higher fees and taxes compounded the cost of holding property in Australia as a foreigner. “That’s pushing foreign buyers out of the market. Even if you could afford to buy it, you have to be able to afford to keep it, and that’s why people are selling,” Li said. “Overseas purchasers are cash rich, so they have assets overseas – not just Chinese, I’m talking about Persian, Lebanese, Americans, British. Normally, they sell their assets [to buy in Australia]. So the mortgage is not a big concern ... it’s the surcharges.” He said foreign buyers have been declining since the introduction of fees and surcharges in 2017, especially in unit-heavy markets such as Sydney’s Chatswood and Burwood. Li said they could once sell an entire development to foreign buyers before the introduction of the FIRB application fees and surcharges, but would now struggle to sell one in 10 to them. Cuts to migration levels and increasing difficulties in qualifying for permanent residency were driving foreign buyers from Australian real estate, Li said, which he did not think would improve. OH Property Group’s Henny Stier noted fewer foreign buyers in Sydney’s north and north shore. “A lot of new builds and apartments in places like Epping have dropped ... if they’re not buying, then local buyers are not buying them, so they’re sitting around on the market and prices are dropping,” Stier said. It was more difficult to move cash from countries like China and Indonesia where there were strict limits on withdrawals, Stier said. Stier added the Australian government’s attempts to disincentivise foreign investment were working. In Melbourne, the top destination for Chinese buyer interest in Australia, foreign buyers face an 8 per cent stamp duty fee. Foreign buyers are subject to extra stamp duty costs. Credit: Paul Rovere Director at Belle Property Balwyn Robert Ding said overseas buyers were delaying property purchases until they obtain permanent residency, when the increased stamp duty no longer applies. “When someone’s paying $4 million to $5 million [for a property], it’s quite a hefty fee,” Ding said. “What a lot of these foreign buyers do ... is rent or even buy something of a less substantial value. Once they get permanent residency, which usually takes about four or five years, that’s when they start to buy properties.” Ray White Balwyn director Helen Yan has noticed a downturn in Chinese buyers since the start of this year, when the federal government paused applications for the significant-investor visa which requires recipients to invest $5 million in Australia. “That’s why the high-end property [market] has slowed down a lot,” Yan said. AMP chief economist Shane Oliver said the number of foreigners buying in Australia has probably returned to pre-COVID levels following the post-pandemic housing boom. “Foreign buying was quite weak through the pandemic years because of travel restrictions,” Oliver said. “That sort of slowed down through the pandemic, then there was a bounce back, and I suspect it’s now just settling down after that initial bounce back. “There could also be some cooling associated with the backlash we’re seeing against foreign students, with student visa numbers down, which may have, to some degree, weighed on foreign purchases as well.”Sean ‘Diddy’ Combs’ third bid to be released on bail won’t be decided until next week
SOUTH KOREA, — A jetliner skidded off a runway, slammed into a concrete fence and burst into flames Sunday in South Korea after its landing gear apparently failed to deploy. All but two of the 181 people aboard were killed in one of the country’s worst aviation disasters, officials said. The 737-800 operated by Jeju Air plane arrived from Bangkok and crashed while attempting to land in the town of Muan, about 290 kilometers (180 miles) south of Seoul. Footage of the crash aired by South Korean television channels showed the plane skidding across the airstrip at high speed, evidently with its landing gear still closed, and slamming into the wall, triggering an explosion and generating plumes of thick, black smoke. The crash killed 179 people, the South Korean fire agency said. Emergency workers pulled two crew members, to safety. They were conscious and did not appear to have any life-threatening injuries, health officials said. Lee Jeong-hyeon, chief of the Muan fire station, told a televised briefing that the plane was completely destroyed, with only the tail assembly still recognizable in the wreckage. Officials were investigating the cause of the crash, including whether the aircraft was struck by birds, Lee said. The control tower issued a warning about birds to the plane shortly before it intended to land and gave the crew permission to land in a different area, ministry officials said. The crew sent out a distress signal shortly before the crash, officials said. Senior Transport Ministry official Joo Jong-wan said workers retrieved the jet's flight data and cockpit voice recorders. He said it may take months for investigators to complete their probe. The runway at the Muan airport will be closed until Jan. 1, the ministry said. Video of the crash indicated that the pilots did not deploy flaps or slats to slow the aircraft, suggesting a possible hydraulic failure, and they did not manually lower the landing gear, suggesting they did not have time, said John Cox, a retired airline pilot and CEO of Safety Operating Systems in St. Petersburg, Florida. Despite that, the jetliner was under control and traveling in a straight line, and damage and injuries likely would have been minimized if not for a barrier being placed so close to the runway, Cox said. Another aviation expert said videos showed the aircraft had used up much of the runway before touching down. With little braking ability, the aircraft skidded atop its engine cowlings, said Ross “Rusty” Aimer, CEO of Aero Consulting Experts. “It's basically like skidding on ice,” he said. The Boeing 737-800 is a "proven airplane" that belongs to a different class of aircraft than the Boeing 737 Max jetliner that was linked to fatal crashes in 2018 and 2019, added Alan Price, a former chief pilot at Delta Air Lines and now a consultant. More than 4,500 of the planes are in service around the world, according to the aviation analytics company Cirium. One of the survivors was being treated for fractures to his ribs, shoulder blade and upper spine, said Ju Woong, director of the Ewha Womans University Seoul Hospital. Ju said the man, whose name was not released, told doctors he “woke up to find (himself) rescued.” Details on the other survivor were not immediately available. The passengers were predominantly South Korean and included two people from Thailand. Officials identified 88 of them in the hours after the crash, the fire agency said. Thailand’s prime minister, Paetongtarn Shinawatra, expressed condolences to the families of those aboard the plane in a post on X. Paetongtarn said she ordered the Ministry of Foreign Affairs to provide assistance. Boonchuay Duangmanee, the father of a Thai passenger, told The Associated Press that his daughter, Jongluk, had been working in a factory in South Korea for several years and returned to Thailand to visit her family. "I never thought that this would be the last time we would see each other forever,” he said. Kerati Kijmanawat, the director of Thailand's airports, confirmed in a statement that Jeju Air flight 7C 2216 departed from Suvarnabhumi Airport with no reports of anything abnormal aboard the aircraft or on the runway. Jeju Air in a statement expressed its “deep apology” over the crash and said it will do its “utmost to manage the aftermath of the accident.” In a televised news conference, the company's president, Kim E-bae, bowed deeply with other senior company officials as he apologized to bereaved families and said he feels “full responsibility” for the crash. He said the company had not identified any mechanical problems with the aircraft following regular checkups and that he would wait for the results of government investigations. Family members wailed as officials announced the names of some victims at a lounge in the Muan airport. Boeing said in a statement on X that it was in contact with Jeju Air and was ready to support the company in dealing with the crash. The crash happened as South Korea is embroiled in a political crisis triggered by President Yoon Suk Yeol’s stunning imposition of martial law and ensuing impeachment . South Korean lawmakers on Friday impeached acting President Han Duck-soo and suspended his duties, leading Deputy Prime Minister Choi Sang-mok to take over. Choi, who traveled to the site in Muan, called for officials to use all available resources to identify the dead as soon as possible. The government declared Muan a special disaster zone and designated a weeklong national mourning period. Yoon’s office said his chief secretary, Chung Jin-suk, presided over an emergency meeting between senior presidential staff to discuss the crash and reported the details to Choi. Yoon expressed condolences to the victims in a Facebook post. In Rome’s St. Peter’s Square, Pope Francis said he joined in “prayer for the survivors and the dead.” The Muan crash is one of the deadliest disasters in South Korea’s aviation history. The last time South Korea suffered a large-scale air disaster was in 1997, when a Korean Airline plane crashed in Guam, killing 228 people on board. In 2013, an Asiana Airlines plane crash-landed in San Francisco, killing three and injuring about 200. Sunday’s accident was also one of the worst landing disasters since a July 2007 crash that killed all 187 people on board and 12 others on the ground when an Airbus A320 slid off a slick airstrip in Sao Paulo, Brazil, and hit a nearby building, according to data compiled by the Flight Safety Foundation, a nonprofit group aimed at improving air safety. In 2010, 158 people died when an Air India Express aircraft overshot a runway in Mangalore, India, and plummeted into a gorge before erupting into flames, according to the safety foundation. ___ Associated Press journalists David Sharp in Portland, Maine; Paul Wiseman in Washington; Bobby Caina Calvan in New York; Chalida Ekvitthayavechnukul and Jintamas Saksornchai in Bangkok; Mari Yamaguchi in Tokyo; and Giada Zampano in Rome contributed to this report.
Edifier Scoops 5 Honours At Prestigious Visual Grand Prix 2025
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare genetic diseases Strong balance sheet with approximately $80.0 million of cash and cash equivalents, including proceeds from a PIPE financing co-led by BVF Partners, L.P. and Frazier Life Sciences Cash expected to fund operations into the second half of 2027, including through Phase 3 SELVA clinical trial of QTORINTM 3.9% rapamycin anhydrous gel (QTORINTM rapamycin) for the treatment of microcystic lymphatic malformations (microcystic LMs) and Phase 2 clinical trial in cutaneous venous malformations (cutaneous VMs) Microcystic LMs is a chronically debilitating and lifelong genetic disease affecting an estimated more than 30,000 diagnosed patients in the U.S. QTORINTM rapamycin has the potential to be the first approved therapy and standard of care in the U.S. for microcystic LMs and cutaneous VMs WAYNE, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced the completion of its previously announced merger with Pieris Pharmaceuticals, Inc. (Pieris). The combined company will operate under the name Palvella Therapeutics, Inc., and its shares are expected to begin trading on the Nasdaq Capital Market on December 16, 2024, under the ticker symbol "PVLA". Palvella will continue to be led by Wes Kaupinen, its Founder and Chief Executive Officer, and other members of the Palvella management team. The transaction was approved by Pieris stockholders at a special meeting held on December 11, 2024, and the transaction had been previously approved by Palvella stockholders. "With strong support from leading healthcare-dedicated investors, Palvella is well positioned to enter the public markets and pursue our vision of becoming the leading rare disease company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases," said Mr. Kaupinen. “This transaction will enable us to accelerate late-stage development of QTORINTM rapamycin, our lead product candidate, for microcystic LMs and cutaneous VMs while also further advancing additional novel product candidates from our QTORINTM platform." Concurrent with the merger, Palvella completed a previously announced oversubscribed $78.9 million private placement co-led by BVF Partners, L.P., an existing investor, and Frazier Life Sciences, a new investor, and with participation from a syndicate of leading healthcare-dedicated investors. Additional new investors include Blue Owl Healthcare Opportunities, Nantahala Capital, DAFNA Capital Management, ADAR1 Capital Management, and a healthcare dedicated fund. Existing investors Samsara BioCapital, Petrichor, CAM Capital, Ligand Pharmaceuticals, Integrated Finance Group (an AscellaHealth partner company), BioAdvance, and Gore Range Capital also participated in the financing. Palvella's cash and cash equivalents of approximately $80.0 million is expected to fund operations into the second half of 2027, including through results from the SELVA Phase 3 clinical trial of QTORINTM rapamycin for the treatment of microcystic LMs and Phase 2 clinical trial of QTORINTM rapamycin in cutaneous VMs. Palvella’s research team developed QTORINTM, a patented and versatile platform designed to generate novel topical therapies that penetrate the deep layers of the skin to locally treat a broad spectrum of serious, rare genetic skin diseases. Well-accepted mechanisms of action of rapamycin and other therapeutic agents represent potential therapies for rare genetic skin diseases. However, the adverse event profile of those agents through systemic exposure poses significant barriers to patient adoption. Palvella’s QTORINTM product candidates are designed for targeted, localized delivery of therapeutic agents to pathogenic tissue of interest while minimizing systemic absorption and thereby reducing the risk of unwanted adverse events associated with systemic therapy. Palvella's lead product candidate QTORINTM rapamycin is a novel, patented 3.9% rapamycin anhydrous gel currently under development for the treatment of microcystic LMs, cutaneous VMs, and other serious, functionally debilitating skin diseases driven by the overactivation of the mammalian target of rapamycin (mTOR) pathway. QTORINTM rapamycin has received FDA Breakthrough Therapy Designation, Fast Track Designation, and Orphan Drug Designation for microcystic LMs and is the recent recipient of up to a $2.6 million FDA Orphan Products Grant. QTORINTM rapamycin has also received Fast Track Designation for venous malformations. QTORINTM rapamycin is protected by issued composition patents covering anhydrous gel formulations of rapamycin, as well as methods of use, in the U.S., Japan, Australia, China and Israel and pending patent applications broadly covering anhydrous gel formulations of rapamycin, as well as methods of use, in the U.S. and other countries. In the third quarter of 2024, Palvella initiated SELVA, a 24-week, Phase 3, single-arm, baseline-controlled clinical trial of QTORINTM rapamycin administered once daily for the treatment of microcystic LMs. The primary efficacy endpoint is the change from baseline in the overall microcystic LM Investigator Global Assessment (mLM-IGA) at week 24. The Phase 3 study is enrolling approximately 40 subjects, age six or older, at leading vascular anomaly centers across the U.S. Transaction Details Based on the final exchange ratio of approximately 0.30946 shares of Pieris common stock for each share of Palvella common stock, at the closing of the merger, there are approximately 13.95 million shares of the combined company's common stock outstanding on a diluted basis, with prior Pieris stockholders owning approximately 11% on a diluted basis and prior Palvella stockholders (including investors in the private placement) holding approximately 89% of the combined company's outstanding common stock on a diluted basis. In connection with the closing of the merger, Pieris issued a non-transferable contingent value right (CVR) to Pieris shareholders of record immediately prior to the closing, which does not include the former holders of shares of Palvella or the private financing investors. Holders of the CVR will be entitled to receive payments from proceeds received by the combined company, if any, under Pieris' existing partnership agreements with Pfizer and Boston Pharmaceuticals, in addition to other potential licensing agreements involving certain of Pieris' legacy assets, as well as certain potential payments related to historical research and development tax credits, which may or may not be realized. TD Cowen served as lead placement agent and Cantor served as a placement agent for Palvella's concurrent financing. Troutman Pepper Hamilton Sanders LLP served as legal counsel to Palvella. Cooley LLP served as legal counsel to the placement agents. Stifel served as the exclusive financial advisor to Pieris and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C. served as legal counsel to Pieris. About Microcystic Lymphatic Malformations Microcystic LMs are a rare, chronically debilitating genetic disease caused by dysregulation of the phosphatidylinositol 3-kinase (PI3K)/mTOR pathway. The disease is characterized by malformed lymphatic vessels that protrude through the skin and persistently leak lymph fluid (lymphorrhea) and bleed, often leading to recurrent serious infections and cellulitis that can cause hospitalization. The natural history of microcystic LMs are persistent and progressive without spontaneous resolution, with symptoms generally worsening during life, including increases in the number and size of malformed vessels that lead to complications and lifetime morbidity. There are currently no FDA-approved treatments for the estimated more than 30,000 diagnosed patients with microcystic LMs in the United States. About Palvella Therapeutics Founded and led by rare drug disease drug development veterans, Palvella Therapeutics (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORINTM platform, with an initial focus on serious, rare genetic skin diseases, many of which are lifelong in nature. Palvella’s lead product candidate, QTORINTM 3.9% rapamycin anhydrous gel (QTORINTM rapamycin), is currently in the Phase 3 SELVA clinical trial in microcystic lymphatic malformations (microcystic LMs) and a Phase 2 trial in cutaneous venous malformations. For more information, please visit www.palvellatx.com or follow the Company on LinkedIn. QTORINTM rapamycin is for investigational use only and has not been approved or cleared by the FDA or by any other regulatory agency. This press release contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended (Securities Act)). These statements may discuss goals, intentions, and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the management of Palvella and Pieris, as well as assumptions made by, and information currently available to, management of Palvella and Pieris. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” and other similar expressions or the negative or plural of these words, or other similar expressions that are predictions or indicate future events or prospects, although not all forward-looking statements contain these words. Statements that are not historical facts are forward-looking statements. Forward-looking statements include, but are not limited to, the sufficiency of the combined company’s capital resources; the combined company’s cash runway; the expected timing of the closing of the proposed transactions; statements regarding the potential of, and expectations regarding, Palvella’s programs, including QTORINTM rapamycin, and its research-stage opportunities, including its expected therapeutic potential and market opportunity; the expected timing of initiating, as well as the design of Palvella’s Phase 2 clinical trial of QTORINTM rapamycin in cutaneous venous malformations. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the limited operating history of each company; the significant net losses incurred since inception; the ability to raise additional capital to finance operations; the ability to advance product candidates through preclinical and clinical development; the ability to obtain regulatory approval for, and ultimately commercialize, Palvella’s product candidates, including QTORINTM rapamycin; the outcome of early clinical trials for Palvella’s product candidates, including the ability of those trials to satisfy relevant governmental or regulatory requirements; the fact that data and results from clinical studies may not necessarily be indicative of future results; Palvella’s limited experience in designing clinical trials and lack of experience in conducting clinical trials; the ability to identify and pivot to other programs, product candidates, or indications that may be more profitable or successful than Palvella’s current product candidates; the substantial competition Palvella faces in discovering, developing, or commercializing products; the negative impacts of the global events on operations, including ongoing and planned clinical trials and ongoing and planned preclinical studies; the ability to attract, hire, and retain skilled executive officers and employees; the ability of Palvella and Pieris to protect their respective intellectual property and proprietary technologies; reliance on third parties, contract manufacturers, and contract research organizations. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the risk factors included in Pieris’ most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with the SEC, as well as the registration statement on Form S-4 filed with the SEC by Pieris in connection with the merger. Palvella and Pieris can give no assurance that the conditions to the proposed transactions will be satisfied. Except as required by applicable law, Palvella and Pieris undertake no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. This press release contains hyperlinks to information that is not deemed to be incorporated by reference into this press release. Palvella Therapeutics Contact Information Investors Wesley H. Kaupinen Founder and CEO, Palvella Therapeutics wes.kaupinen@palvellatx.com Media Stephanie Jacobson Managing Director, Argot Partners palvella@argotpartners.comSEATTLE (AP) — The Seattle Seahawks were struggling a week ago, coming off their bye having lost five of their last six games. That included a gut-punch overtime defeat at home against the Los Angeles Rams on Nov. 3. The outlook for the last-place Seahawks (5-5) was beginning to look grim. They suddenly have renewed optimism this week after an uplifting victory over the San Francisco 49ers that snapped a six-game losing streak against their arch-rival that dated to 2021. Seattle will play the first-place Arizona Cardinals (6-4) on Sunday for a share of the NFC West lead. How quickly things change in the NFL. “We’ve earned the opportunity to be fighting for the lead in the division going into the home stretch,” Seahawks coach Mike Macdonald said. “So that’s the way we’re treating it. It’s very much like a playoff mindset for us at this point.” The win over the 49ers, which was capped by a 13-yard touchdown run by quarterback Geno Smith with 18 seconds left, put the Seahawks in a much better place mentally than they’d been in over the previous six weeks. They're hoping it's just the start of something even bigger. “It can just spark something that you’ve been looking for this whole year,” wide receiver DK Metcalf said. “I know we started off very hot with the first three games, but, you know, when adversity hit, it’s all about how you respond. I think we responded the right way, and it’s going to carry us throughout the rest of the season.” While the Seahawks are feeling better this week, the Cardinals have plenty of reason to feel optimistic, too. After starting the season 2-4, Arizona has won four straight to put itself in first place in the NFC West. The Cardinals have a defense that is making big strides under the leadership of veteran safety Budda Baker and a top-five running game behind the dual threat of running back James Conner, who has 697 yards rushing, and quarterback Kyler Murray, who seems to be hitting his stride in his sixth NFL season. Murray has 2,058 yards passing with 12 touchdowns, and has rushed for 371 yards and four scores. Second-year head coach Jonathan Gannon has been impressed with Murray’s improved decision-making as Murray has thrown just three interceptions through 10 games. “There’s times that he probably wants to try to thread it a little bit, but understands when to pick and choose his spots,” Gannon said. “I think he’s done a phenomenal job with that and there are a lot of times throughout the game where you could say we like to put it in the quarterback’s hands, and you trust him to make the right decision for that point in the game.” Seahawks wide receiver Jaxon Smith-Njigba will see a familiar face on the other sideline Sunday in rookie Marvin Harrison Jr., who was Smith-Njigba’s college teammate at Ohio State in 2021 and 2022. The pair each caught three touchdowns in the Buckeyes’ wild win over Utah in the 2022 Rose Bowl, with Smith-Njigba having 347 yards receiving on what was a 573-passing yard day for C.J. Stroud, now the quarterback of the Houston Texans. “Late his freshman year, he really just stood out,” Smith-Njigba said of Harrison. “You could just see the growth and kind of who he is becoming. ... He’s passed a lot of people’s expectations, of course, but I knew he was going to be elite later on freshman year.” Murray is coming off one of the best games of his career after completing 22 of 24 passes for 266 yards and a touchdown against the Jets two weeks ago. He also ran for 21 yards and two TDs. Murray currently ranks No. 3 in the NFL in quarterback rating behind Cincinnati's Joe Burrow and Baltimore's Lamar Jackson. That has put him in the MVP conversation, particularly since Arizona has won four straight games. “I don’t play the game for the validation of others," Murray said. "But as a player, of course, sometimes the recognition and the words being said feel good. But it doesn’t satisfy me.” The most surprising part of Arizona’s four-game winning streak is the rapid improvement of the defense, which has allowed just 9 and 6 points, respectively, over the past two games. No touchdowns have been allowed – just five field goals. It’s just the second time over the past 30 years that the franchise has allowed 10 points or less over back-to-back games. Baker, a Bellevue native and former University of Washington football star, is the unquestioned leader of the bunch – he already has 100 tackles over 10 games - but the team also has a strong core of linebackers in Kyzir White, Mack Wilson and Zaven Collins. Metcalf and Baker have gone up against each other many times before, most famously when Metcalf ran Baker down on an interception return in 2020. “You really can’t prepare for a guy like that because his engine never stops,” Metcalf said. “He’s always going to be around the ball. He’s always going to affect the game with just his play effort and play style. ... Just got to try to minimize his playmaking ability as much as we can on offense.” AP Sports Writer David Brandt in Phoenix, Arizona, contributed to this report. AP NFL: https://apnews.com/hub/nflNYC officials want answers from NYPD, FBI about disconcerting drone sightings
Trump world sure does have a strange affection for acquitted killers
Stock market 12-02-24: Rising tech stocks pull Wall Street to another recordThe world of Sanctuary is evolving. With the latest update to Diablo 4, Blizzard Entertainment is not only refining the gameplay but also integrating groundbreaking technology that promises to redefine player immersion. The upcoming patch leverages cutting-edge AI to create dynamically evolving game environments, a first for the series. Through procedural generation enhanced by AI, each player’s journey will be uniquely tailored, making every dungeon delve an unrepeatable adventure. Adaptive AI is the key. This innovative approach allows the game world to respond to players’ decisions in real-time, altering enemy behavior and environmental factors based on player actions and patterns. For instance, if a player is adept at long-range combat, the AI may adjust the enemy’s strategies to encourage close-quarter confrontations, keeping challenges fresh and pushing players to adapt continuously. With AR technology, immersion takes a leap. The developers are also experimenting with augmented reality (AR) for potential future updates. Imagine strategizing for your next quest while seeing the maps and characters come alive in your living room. Though still in experimental stages, this feature could blend the boundaries between gaming and reality, offering a more interactive and immersive experience. This update is more than just a patch; it’s a glimpse into the future of gaming. Diablo 4’s integration of technologies like AI and AR hints at a new horizon where games become ever more personalized and interactively rich, flagging a new era for RPG enthusiasts and setting a benchmark for the industry. Diablo 4’s Technological Revolution: A Glimpse Into Gaming’s Future In the evolving world of Sanctuary, Blizzard Entertainment is pushing the boundaries of player experience with its latest update to Diablo 4. By integrating groundbreaking technologies such as advanced AI and experimental augmented reality (AR), the franchise promises an unparalleled level of immersion and personalization. AI-Powered Worlds: A New Era in Gaming The core innovation lies in the adaptive AI system, which not only enhances procedural generation but also tailors the gaming experience to individual players. This dynamic system creates a world that responds intelligently to player decisions, offering a one-of-a-kind journey each time. As the AI modifies enemy strategies based on a player’s combat style, gamers are constantly challenged and forced to refine their gameplay strategies, making the virtual experience perpetually engaging. Pros and Cons of AI Integration in Diablo 4 Pros: – Personalized Gameplay: Each player’s journey is unique, ensuring replayability and continuous engagement. – Dynamic Challenges: Adaptive AI provides varied challenges, requiring players to continuously adapt. – Immersive Experience: Enhanced realism through responsive game environments. Cons: – Complexity: New players may find the dynamic changes overwhelming. – Learning Curve: Adaptive strategies may require a deeper understanding of game mechanics. The Promise of Augmented Reality While AR technology in Diablo 4 remains experimental, its potential to merge the digital and physical world could revolutionize interactive storytelling within role-playing games. Envisioning a realm where game maps and characters can be projected into real-world settings opens new avenues for immersive gameplay experiences. Although this feature is yet to be fully realized, its incorporation could redefine users’ interaction with game environments. Market Predictions and Future Innovations With the implementation of these advanced technologies, Diablo 4 positions itself as a pioneer among RPGs, setting new standards for interactive and personalized gaming. The industry’s focus is shifting toward experiences that are not only visually stunning but also intelligent and adaptable, marking a significant trend in the future of game design. Expectations are that other game developers will follow suit, integrating similar AI-driven and AR-enhanced features to keep pace with evolving player expectations. As technology continues to develop, the line between reality and gaming is likely to blur further, leading to an era where video games offer unparalleled immersion and engagement levels. For more information on Diablo 4’s innovations, visit the official Blizzard Entertainment website.
The CBS series “ Watson ” will premiere after the AFC Championship Game on Jan. 26, 2025, on CBS and also be available to stream on Paramount+. The series will air regularly starting Feb. 16. “Watson” takes place six months after the death of the titular character’s friend and partner Sherlock Holmes at the hands of Moriarty. The show stars Morris Chestnut as Dr. John Watson, who resumes his medical career as the head of a clinic dedicated to treating rare disorders. Per the logline, “Watson’s old life isn’t done with him, though – Moriarty and Watson are set to write their own chapter of a story that has fascinated audiences for more than a century. Watson is a medical show with a strong investigative spine, featuring a modern version of one of history’s greatest detectives as he turns his attention from solving crimes to solving medical mysteries.” The cast also includes Eve Harlow, Peter Mark Kendall, Ritchie Coster, Inga Schlingmann and Rochelle Aytes. Watch the official trailer below. * “Henry Danger The Movie,” based on the Nickelodeon live action show, premieres on the channel Jan. 17 at 7 p.m. and will be available to stream on Paramount+ the same day. A teaser is available now. The movie stars members of the original series cast including Jace Norman as Henry Danger, Sean Ryan Fox as Jasper, Ella Anderson as Piper Hart, Michael D. Cohen as Schwoz, and Frankie Grande as Frankini. Glee Dango will play the new character of Missy Martin/Superfan. The film description reads, “Henry finds himself racing through a maze of alternate realities with his new superfan sidekick.” Watch the teaser below. * The 1997 musical “The Full Monty” is the inspiration for Fox’s “ The Real Full Monty ,” a new two-hour special where a group of male celebrities (almost) bare all for charity; the network has just unveiled a first look. The special is meant to help raise awareness for prostate, testicular and colorectal cancer testing and research, encouraging men to get checked on a regular basis. The cast features host Anthony Anderson, Taye Diggs (“All American,” “How Stella Got Her Groove Back”), Tyler Posey (“Teen Wolf”), Bruno Tonioli (“Dancing with the Stars”), James Van Der Beek (“Dawson’s Creek,” “Varsity Blues”) and super bowl champion Chris Jones. Van Der Beek recently revealed his own diagnosis with colorectal cancer. During the special, Anderson will be lead the male cast to train and rehearse for a revealing performance choreographed by Mandy Moore (“La La Land,” “So You Think You Can Dance”). Throughout their journey, the celebrities will share their personal stories and how cancer impacted their lives. The special airs Monday, Dec. 9 on Fox. Check out the first look promo below. * The frantic search for a father in a rural community provides the seed of conflict in BYUtv’s adaptation of “Primrose Railway Children.” This story is adapted from author Jacqueline Wilson’s novel of the same name, which itself is a modern-day retelling of Edith Nesbit’s 1905 “The Railway Children.” After a young Phoebe (Ava Joyce McCarthy) and her siblings are forced to move to a Scottish village, their father ( Kevin McKidd ) goes missing. Phoebe takes it upon herself to get to the bottom of her father’s disappearance and along the way, discovers connections and secrets in her new community. The adaptation will be available to stream for free on the BYUtv app and at BYUtv.org starting Dec. 8. “Primrose Railway Children” was produced by BYUtv in partnership with BBC Studios Kids & Family Productions. Watch the first look trailer below. AWARDS Queen Latifah will host the 47th Annual Kennedy Center Honors , set to air Sunday, Dec. 22 on CBS before streaming on Paramount+. This marks Latifah’s first time hosting the special. Over the past 46 years, the Kennedy Center Honors has celebrated individuals who have made a mark in the performing arts, whether it be film, television, music, theater, dance or opera. Latifah stars in and executive produces CBS’ “The Equalizer.” She is a Grammy-award winning musician for her rap single “U.N.I.T.Y.” and an Oscar-nominated actress for her role in the film adaptation of “Chicago.” Most recently, she was a 2023 honoree at the 46th Annual Kennedy Center Honors. Done+Dusted will produce the ceremony for the third time in association with ROK Productions. The event is directed by Alex Rudzinski and executive produced by David Jammy, Elizabeth Kelly and Jack Sussman. PROGRAMMING Matt Iseman, the host of NBC’s “American Ninja Warrior,” will take over the reins of “On Patrol: Live” on Nov. 29 and 30. This marks the second time Iseman will be filling in for regular host Dan Abrams over the holiday weekend. “On Patrol: Live” provides minute-by-minute live analysis of police officers on patrol working in diverse departments across the United States. Iseman has previously hosted live coverage of three Olympic Games for Peacock and “Live Rescue” on A&E. He has appeared on “The Kelly Clarkson Show,” “Lip Sync Battle,” “Hollywood Game Night” and “RuPaul’s Celebrity Drag Race.” The show airs Friday and Saturday nights from 9 p.m. to 12 a.m. ET on Reelz, and streams live on Peacock. Executive producers include Dan Cesareo, John Zito, Lucilla D’Agostino, Paul Gordon, Joe Venafro and Dan Abrams. AWARDS
Adani Group says it lost $55b as US charges sparked rout
Public health advocates rail against Trump’s nomination of RFK Jr. for cabinet postA SURPRISING Strictly Come Dancing feud has been revealed with just hours before the celebs reunite at the show's grand final. One star has dealt a brutal blow to four of her co-stars in an unexpected move. Toyah Wilcox, 66, has seemingly scrubbed four of this year's Strictly celebs, including two finalists, from her social media. The singer appears to have dramatically unfollowed the select celebs from her Instagram account. Final stars Tasha Ghouri and Chris McCausland are among those who Toyah has opted fall out of touch with as well as last week's evictee Pete Wicks and EastEnders actor Jamie Borthwick. The reasoning behind Toyah's decision is unclear but with all of this year's cast set to be back together for Saturday's final, the timing is very telling. Toyah has not addressed any feuds but her subtle move appears to have made her feelings clear ahead of the last episode of the series. At the start of the series, Toyah came under fire as she appeared to take a pop at Chris on It Takes Two. She took a savage swipe at Chris in a rather awkward moment on the BBC Two spin-off show back in October. Host Fleur East asked her: "You are such a tightknit group as well this year, do you have any advice or tips for the other celebs?" Toyah laughed and started clapping, before pointing at the camera and shouting: "If you don't want to do a dance off, get rid of Chris!" She then cackled and fell into Neil's lap while Neil and Fleur looked on and laughed awkwardly. Toyah's surprising comment did not going unnoticed by viewers watching at home, who took to social media to react. One wrote on X: "Was Toyah trying to throw Chris under the bus!!" A second chipped in: Was it panic I saw on their faces when Toyah said ‘get rid of Chris if you don’t want to do a dance off ‘ ...little does she realise Chris is a 100x better dancer than she [was] and he is there on merit." She l ater clarified that she meant no ill will by her commen t just a day later and insisted that Chris was her winner, saying: "Just to clarify and to clear up any confusion that’s flying around. "My good friend @chrismccausland, is my favourite to win this year, I think he is inspiring and brilliant, he has worked so hard and I wish him nothing but love! Toyah x" But it now appears that her stance has changed after she chose to dissociate with him online. It will leave Strictly fans keeping a very close eye on Toyah and her fellow celebs as they all take to the dancefloor one final time. Strictly first kicked off back in 2004, and over the years has crowned 21 winners. Here is a full list of who has been lucky enough to win the famous Glitterball Trophy :
No. 25 UConn working on climbing back up poll, faces No. 15 BaylorATLANTA — To improve Georgia’s troubled prison system, the General Assembly should hike correctional officer salaries, consider more private-public partnerships to expand capacity, increase mental health services and move to single-person cells to improve safety. Those are among a slate of recommendations that a state Senate study committee approved Friday, following hours of testimony at a series of meetings that began in August. Other recommendations that won approval include asking for an audit of contracts to identify any excessive vendor costs, ordering a compensation study, prioritizing new technology to improve security at current and new facilities, and taking action to make sure wardens adhere to consistent policies to prevent culture differences among facilities. The committee also recommended that the state seek federal approval to jam cellphone signals at prisons. Prisoners have used cellphones to run criminal enterprises from inside the prisons, including directing drug trafficking networks and operating various fraud schemes. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.Egypt has tested a new 10-kilometre (6.2-mile) extension to the Suez Canal as it tries to minimise the impact of currents on shipping and increase the key waterway's capacity. ET Year-end Special Reads What kept India's stock market investors on toes in 2024? India's car race: How far EVs went in 2024 Investing in 2025: Six wealth management trends to watch out for Two ships used the new extension on Saturday, a statement from the Suez Canal Authority said. Authority chief Osama Rabie said the development in the canal's southern region will "enhance navigational safety and reduce the effects of water and air currents on passing ships". Vessels navigating the waterway have at times run aground, mostly because of strong winds and sandstorms. In 2021, giant container ship Ever Given became wedged diagonally in the canal, blocking trade for nearly a week and resulting in delays that cost billions of dollars. Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrows Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program The new extension is set to boost the canal's capacity by six to eight vessels a day, Rabie said, and it will open after new navigational maps are issued. In 2015, Egypt undertook an $8-billion expansion to the waterway, followed by several smaller development projects. The Suez Canal has long been a vital source of foreign currency for Egypt that has been undergoing its worst ever economic crisis. According to the International Monetary Fund, revenue from the canal has been slashed by up to 70 percent since last year because of attacks by Yemen's Iran-backed Huthi rebels on shipping in the Red Sea. Before the attacks pushed companies to change routes, the vital passage accounted for around 10 percent of global maritime trade . (You can now subscribe to our Economic Times WhatsApp channel )